Wikipedia -WSS

Wikipedia

author：fashion 2025-10-04 11:42:51 - browse：19

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： 2023 Nobel Prize in Medicine goes to Karikó and Weissman

WSS

Nobel honors Karikó and Weissman's enduring partnership

6 solutions to address cancer drug shortages and others

2023 Nobel Prize in Medicine goes to Karikó and Weissman

The biotech scorecard for Q4: 16 stock

Publishing genetic code of viruses could cause disaster

WHO recommends second malaria vaccine

leisure time

Wikipedia

Wikipedia

How to save PrEP access — and even expand it

Health insurers' Q3 question: how much care are people getting?

Moonlake's readout produced a cash windfall. Risks remain

Medicare’s new pay boost for primary care is angering specialists

Alkermes shareholders re

White House drug czar issues call for 'recovery

As demand for Covid shots wanes, Moderna seeks its next success

The United States is paying nearly triple for new Covid vaccines

DIEP, the 'gold standard' of breast reconstruction, is under threat

CVS, Rite Aid closures threaten to worsen pharmacy deserts

hotspot

How state and local governments are sidelining science

Readout Newsletter: Zepbound, Valneva's vaccine, and more

NIH chief: government has fallen behind pharma on clinical trials

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

FDA reorg will put new emphasis on investigations, sources say

Ohio still needs to do more to protect the right to abortion

hotspot

focus

focus

explore